Arrhythmia/EP
Digitek digoxin tablets recalled: Possible double dose released by accident
Apr 29, 2008 | Shelley Wood

Morristown, NJ - The manufacturer of Digitek digoxin tablets is recalling the product, saying that it may have accidentally released pills that are double the normal thickness, carrying twice the normal dose [1].

Digoxin is used in the treatment of arrhythmias and heart failure, and a double dose could cause toxicity, most notably in patients with renal failure. According to a press release from Digitek's manufacturer, Actavis, digitalis toxicity "can cause nausea, vomiting, dizziness, low blood pressure, cardiac instability, and bradycardia," and even death.

The FDA is alerting doctors and the public to the recall via its MedWatch program. The agency notes that several reports of illness and injury have been reported. Digitek is distributed by Mylan Pharmaceuticals under a Bertek label and by UDL Laboratories under a UDL label, the Actavis press release notes.

Source
  1. Actavis. Actavis Totowa (formerly known as Amide Pharmaceutical Inc) recalls all lots of Bertek and UDL Laboratories Digitek (digoxin tablets, USP) as a precaution [press release]. April 25, 2008. Available at: http://www.actavis.us/en/media+center/newsroom/articles/digitek+recall.htm.



You have to be logged in to add a comment to this article
Login
Username 
Password 
  Forgot your password?
 
Remember me on this computer
 
Join theheart.org community
Five reasons to become a member of the most trusted source of cardiology news:
1Be part of the conversation in our blogs and discussion forum
2Share your thoughts on our news or educational programs
3Receive exclusive newsletters related to your field of interest
4Access unique continuous medical education content
5See and read what leaders have to say about cardiology today
It is free and it only takes five minutes to join!
 
button
Previews
Featured CME
Inside: Arrhythmia/EP